A trendy “plant tonic” that promises focus and relaxation is quietly becoming a public health concern. Walk into a gas station or vape shop in many parts of the United States and you’ll see them lined up near the counter little blue bottles with the words Feel Free printed on the label. Marketed as a natural way to boost mood, productivity, and focus, the two-ounce shots look as harmless as kombucha or an energy drink. But behind their wellness branding lies an ingredient that doctors, regulators, and recovering users say can wreak havoc: kratom.

What began as a boutique herbal tonic has grown into a nationwide phenomenon. And for some people, that harmless-looking bottle has led to cycles of dependency, debt, and even rehab.

Also Read: What Is Chagas Disease? What Are the Symptoms? Is This 'Kissing Bug' Infection Deadly?

Feel Free is made by Botanic Tonics, a Texas-based company that launched the product in 2020. Its formula blends two herbal ingredients: kava root, traditionally used in Pacific Island cultures for relaxation, and kratom, a Southeast Asian plant with stimulant and opioid-like properties.

At first glance, it seems to fit right into America’s booming functional beverage market. The company advertises it as a caffeine-free energy boost and stress reliever “plant ingredients for productivity and focus.” It’s now sold in more than 24,000 convenience stores, smoke shops, and health food outlets across the country. Priced between $8 and $13 a bottle, the drink has become popular among students, young professionals, and even parents looking for a “natural” alternative to alcohol or coffee.

But what the label doesn’t highlight is the risk of dependence. Feel Free comes with a serving suggestion of one ounce, half a bottle, and a warning that it “may be habit-forming.”

What Are Kratom's Effects?

Kratom, scientifically known as Mitragyna speciosa, has been used in Southeast Asia for centuries. Laborers chewed its leaves for energy, while traditional healers brewed it as a tea for pain or diarrhea.

Also Read: COVID Symptoms Are Different In 2025—How Long After Exposure Should You Get Tested?

In the US, kratom began appearing in the late 1990s and quickly developed a following among people looking for alternatives to opioids or antidepressants. Today, nearly 2 million Americans are estimated to use kratom in some form — powders, capsules, extracts, or beverages like Feel Free.

The problem lies in how kratom interacts with the brain. Its alkaloids, primarily mitragynine, bind to the same receptors as opioids. At low doses, kratom can act like a stimulant. At higher doses, it produces sedative and euphoric effects. The U.S. Food and Drug Administration (FDA) has classified it as an opioid, citing risks of dependence, withdrawal, liver damage, and — in rare cases — overdose.

Despite these warnings, kratom remains unregulated at the federal level. Only a handful of states, including Alabama, Indiana, and Rhode Island, have banned it outright. In much of the country, it can be purchased legally by anyone, including minors, from gas stations and corner shops.

Why Has Social Media Sparked Alarm on Feel Free Drink?

Awareness of Feel Free’s addictive potential gained traction on TikTok, where users shared cautionary tales of dependency. In one viral video, Texas resident Misha Brown recounted being approached by a teenager who tried to convince him to buy Feel Free from a Circle K store. When he refused, the boy attempted to grab his wallet.

Inside the store, Brown said the attendant explained that customers came in “six times a day” for the product. The video, which garnered more than 23 million views, ignited a wave of comments from young people describing their own struggles with Feel Free — from financial strain to full-blown withdrawal symptoms.

Also Read: World Sexual Health Day 2025: Theme, Significance And What You Can Do To Make Sexual Wellness Everyday Health

For many, what started as an occasional pick-me-up quickly escalated into a daily habit.

Feel Free: How A Wellness Drink Turned Into A Nightmare With Major Health Risks?

Addiction medicine specialists are now sounding the alarm. Dr. Robert Levy, an associate professor at the University of Minnesota Medical School, has treated numerous patients for kratom dependency. Withdrawal symptoms can mirror those of opioids: nausea, sweating, insomnia, irritability, and severe cravings.

The risk is compounded by Feel Free’s formula. While kratom stimulates, kava depresses the nervous system. Each herb acts on different receptors in the brain, kava on the same ones as benzodiazepines like Xanax, and kratom on opioid receptors. Combined, they can create an overstimulating and destabilizing effect that heightens the likelihood of dependence.

Some users report drinking multiple bottles a day, far exceeding the recommended limit. The cost alone can lead to financial stress, while abrupt attempts to quit often result in withdrawal that drives people back to the drink.

Regulation and Legal Gray Areas

The FDA has repeatedly warned against kratom use, but it remains stuck in regulatory limbo. In 2016, the Drug Enforcement Administration (DEA) proposed classifying kratom’s compounds as Schedule I drugs, alongside heroin and LSD, but backed down after intense lobbying from advocacy groups.

More recently, the FDA recommended tighter control of products containing 7-OH, a synthetic kratom derivative with even higher abuse potential. But Feel Free contains natural kratom leaf extract, which falls outside those recommendations.

Meanwhile, Botanic Tonics has faced lawsuits over claims that its marketing misled customers about potential risks. In 2024, the company agreed to a class-action settlement, though it did not admit wrongdoing. It has since updated labels to emphasize warnings — but insists the drink is safe when used as directed.

Why Is Kratom-Based Drinks Growing Public Health Debate?

The popularity of Feel Free highlights a larger issue: the booming U.S. market for “natural” supplements that skirt the edges of regulation. Unlike prescription medications, products like kratom tonics are not required to undergo rigorous clinical trials or FDA approval before hitting shelves.

That leaves consumers with little reliable information about safety, dosage, or long-term effects. And when a product is packaged like an energy shot, sold next to candy and soda, and advertised as a wellness aid, it’s easy for people — especially young ones — to underestimate its risks.

Should Gas Station Wellness Drinks Feel Free With Kratom Be Better Regulated?

Experts say more research is urgently needed. While some studies suggest kratom may have therapeutic potential for pain management or opioid withdrawal, the risks of dependence and misuse cannot be ignored.

For now, consumers are largely left to navigate the market on their own. Health officials advise those struggling with Feel Free or other kratom products to seek professional help, either through their primary care provider or addiction treatment programs.

Parents are encouraged to talk openly with their children about kratom and similar substances. Signs of use may include mood swings, social withdrawal, digestive issues, or unexplained financial strain.

Also Read: Legionnaires’ Outbreak Canada: 94 Sick So Far, Ontario Food Manufacturer's Cooling Tower Could Be Source Of The Deadly Disease

Feel Free was launched as a lifestyle drink for relaxation and focus, but its addictive potential has become impossible to ignore. It sits at the intersection of America’s appetite for quick fixes, the booming supplement industry, and gaps in regulation.

What looks like a harmless blue bottle can, for some, become the start of a struggle with dependence. Until stronger oversight and clearer science emerge, consumers are left with a difficult truth: “natural” does not always mean safe.

One in seven Indians, or over 14 percent of the population, suffers from some form of mental health disorder. Amid an increasing treatment gap -- up to 90 percent -- seen in several states, especially in North India, the government today reiterated the plan of launching a second National Institute of Mental Health and Neurosciences (NIMHANS) in the northern states.

NIMHANS-2 was first announced by Finance Minister Nirmala Sitharaman during the Union Budget 2026-27, to deliver specialized care for mental health and neurological disorders in north India.

Health experts and policymakers, as part of the government-led Post-Budget Webinar series, highlighted the growing burden of mental and neurological disorders in India and also stressed the urgent need to strengthen institutional capacity to meet emerging healthcare demands.

"One in seven Indians is affected by mental health disorders, while several states continue to face a treatment gap ranging from 70 to 90 percent," the experts said.

Noting that Non-Communicable Diseases (NCDs) account for over 60 percent of deaths in the country, they added that "neurological and mental health conditions are among the leading contributors to disability-adjusted life years (DALYs)," among the citizens.

Need For Tertiary Neuro-psychiatric Care

To address these, the experts called for ramping up tertiary mental health institutions and expanding specialized services.

The session, moderated by Vijay Nehra, Joint Secretary, Ministry of Health and Family Welfare, highlighted that North India currently lacks adequate tertiary neuro-psychiatric care facilities. These include areas such as:

• advanced neuroimaging,
• neurocritical care,
• specialized neurological services

Further, making a virtual address at the Post-Budget Webinar, Union Health Minister JP Nadda also highlighted the government’s focus on strengthening mental healthcare services in the country.

"NIMHANS-2 will be established in North India to expand advanced clinical care, training, and research," Nadda said.

"In addition, the Central Institute of Psychiatry, Ranchi, and the Lokopriya Gopinath Bordoloi Regional Institute of Mental Health, Tezpur, will be upgraded as regional apex institutions to strengthen mental healthcare services in the eastern and north-eastern regions," he added.

Meanwhile, the experts also stressed the need to improve services in underserved and geographically remote regions, including the northeastern states, through better infrastructure, capacity building, and targeted deployment of trained mental health professionals.

They also discussed strategies for expanding advanced neuro-psychiatric care and reinforcing India’s overall mental healthcare ecosystem. They proposed:

• Adopting a hub-and-spoke model supported by digital health platforms

This would allow tertiary institutions and centers of excellence to provide technical guidance, specialist consultations, and clinical support to district hospitals and community-level health facilities.

"Such a model would strengthen referral pathways and ensure that specialized mental health services are accessible to people even in remote and rural areas," the experts said.

• Integrating services under Tele-MANAS

Both existing and upcoming campuses of NIMHANS must be integrated , as this will enable a robust nationwide tele-mental health network that ensures

• timely counselling,
• psychological support,
• specialist consultations

• Digital follow-up systems

The experts called for the seamless integration of healthcare facilities, aligned with the vision of the Ayushman Bharat Digital Mission and the ABHA ID ecosystem. This, they said, will

• enable continuity of care,
• Improve monitoring of patients,
• Lead to better clinical outcomes

• A national Brain-Mind Cloud Network

The Network proposed under the National Health Mission would connect premier institutions such as All India Institute of Medical Sciences (AIIMS), state medical colleges, and primary healthcare centers through a digitally integrated platform.

It could also facilitate

• unified mental health records,
• AI-based screening tools,
• data-driven clinical decision support systems,
• tele-neuro-psychiatric hubs at regional centers.

California and New Jersey in the US are seeing an uptick in cases of human metapneumovirus (HMPV) -- a virus with no vaccine or treatment.

According to the US Centers for Disease Control and Prevention (CDC), HMPV can cause upper and lower respiratory disease. There is currently no vaccine to prevent it, and no specific antiviral therapy to treat it.

"Most people will recover on their own," the agency noted, but advised people who get sick to drink plenty of liquids, stay home, and rest.

As per the CDC's respiratory dashboard, the cases of HMPV steadily ticked up since November 2025. It accounted for over 5 percent of positive tests the week of February 14 through February 21.

While HMPV is not a "new" virus, having first been discovered in 2001, cases haven't spiked to this level in the US since an outbreak in April 2025, USA Today reported.

The New Jersey Respiratory Surveillance Report cited that about 4 percent of residents in the state are testing positive for HMPV. The HMPV cases, accompanied by RSV, COVID, and flu cases, are surging, increasing the number of people seeking emergency medical care.

As per the public database, WastewaterScan Dashboard, HMPV is rampant in Northern California -- specifically San Francisco, Marin, Vallejo, Napa, Novato, Santa Rosa, Sacramento, and Davis, the Independent UK reported.

What Is HMPV? Is It Dangerous?

HMPV was first discovered in 2001 and is part of the Pneumoviridae family along with the Respiratory syncytial virus (RSV).

HMPV most likely spreads from an infected person to others through:

• the air by coughing and sneezing
• close personal contact, such as touching or shaking hands
• touching objects or surfaces that have the viruses on them, then touching the mouth, nose, or eyes

In the US, HMPV circulates in predictable patterns each year, typically beginning in winter and lasting through spring.

The usually self-limiting and mild symptoms typically last 4 to 5 days. These include:

• cough,
• fever,
• nasal congestion,
• shortness of breath

People at risk include:

• elderly people,
• children,
• people with comorbidities

"The HMPV is not deadly, and there is no evidence of mortality or a severe transmission rate," former Indian Council of Medical Research (ICMR) scientist, Dr. Raman Gangakhedkar, told IANS, during the virus's outbreak in India in 2025.

“The virus may cause pneumonitis-like illness, but the mortality rates are almost unknown so far. HMPV has a global prevalence of about 4 per cent,” he added.

While no vaccine or treatment can prevent HMPV infection, to avoid the infection, individuals must:

Practice good hygiene and cover your mouth and nose with a tissue when coughing or sneezing, or use your elbow, not your hands, for it. And wash your hands properly, especially in healthcare settings.

India is currently working on a vision of preventive and holistic health, said Prime Minister Narendra Modi today, while addressing a series of post-budget webinars.

The Prime Minister highlighted that sectors like health, education, skill, tourism, sports, and culture are the primary vehicles for meeting the goal of “Sabka Saath Sabka Vikas-Fulfilling Aspirations of People”.

Also Read: GLP-1 Weight Loss Drugs Could Now Treat Addiction, Says Study

“India is today working on a grand vision for preventive and holistic health. In the past few years, the country's health infrastructure has been strengthened. Hundreds of new medical colleges have opened in districts,” PM Modi said.

“Through the Ayushman Bharat scheme, access to health services has been extended to every village via wellness centers,” he added.

Emphasizing the vision of preventive and holistic health, the Prime Minister noted the rapid strengthening of health infrastructure and the global popularity of Yoga and Ayurveda.

Demand For Care Economy And Telemedicine

PM Modi specifically drew attention to the emerging 'Care Economy' and the rising demand for caregivers globally, urging experts to develop new training models to empower the youth.

"The population of senior citizens will increase in the country in the coming decade. In many countries of the world, there is a high demand for caregivers,” he said.

"Hence, skill-based employment opportunities for lakhs of youth in the health sector are present. I request that new training models be developed," PM Modi added.

The Prime Minister also spoke about the success of telemedicine in reaching remote areas. However, he stressed the need for further simplifying the user experience and building greater public awareness.

"I believe there is still a need to increase awareness and ease of use in telemedicine," PM Modi said.

Experts Push For Emergency Healthcare Services in India

In a separate session, health experts, policymakers, public health experts, and clinicians deliberated on the Budget Announcement under Para 88: “Strengthening of Emergency & Trauma Care Centers”.

In the Union Budget 2026–27, the Government had announced a major initiative to strengthen emergency healthcare services across the country.

The Government also proposed to strengthen and increase emergency and trauma care capacities by 50 per cent in District Hospitals by establishing emergency and trauma care centers.

The experts highlighted the country's significant burden of emergency medical conditions, including road traffic injuries, heart attacks, strokes, poisonings, burns, snake bites, etc.

While these require timely intervention within the “golden hour” to prevent deaths and long-term disability, emergency beds constitute only a small share of total hospital bed capacity in many district hospitals, highlighting the need for strengthening emergency care infrastructure and systems, the experts noted.

The discussion also highlighted the role of implementation research and data-driven approaches in identifying gaps and improving emergency care systems at the district level.

“Strengthening emergency and trauma care at the district level requires a systematic and outcome-oriented approach that goes beyond infrastructure to focus on performance and service delivery,” said Dr. V.K. Paul, member, NITI Aayog, who moderated the session.

Dr. Paul stressed the need for greater convergence across hospital systems, ambulance networks, and government programs, supported by digital technologies and real-time monitoring.

He also called for continued skilling and upskilling of emergency care personnel to build a strong and responsive emergency care system.